Today: Today, Boston Common Asset Management LLC decides to keep it stake in Aetna Inc. (AET) to the level of $1,121,000

Today, Boston Common Asset Management LLC decides to keep it stake in Aetna Inc. (AET) to the level of $1,121,000

Boston Common Asset Management LLC held its position in Aetna Inc. (NYSE:AET) during the third quarter, Holdings Channel reports. The fund owned 9,710 shares of the company’s stock at the end of the third quarter. Boston Common Asset Management LLC’s holdings in Aetna were worth $1,121,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. FTB Advisors Inc. raised its position in shares of Aetna by 0.7% in the third quarter. FTB Advisors Inc. now owns 880 shares of the company’s stock valued at $101,000 after buying an additional 6 shares during the period. Gerstein Fisher raised its position in shares of Aetna by 0.3% in the second quarter. Gerstein Fisher now owns 2,414 shares of the company’s stock valued at $295,000 after buying an additional 8 shares during the period. Bancorpsouth Inc. raised its position in shares of Aetna by 0.4% in the second quarter. Bancorpsouth Inc. now owns 2,915 shares of the company’s stock valued at $356,000 after buying an additional 13 shares during the period. Simmons Bank raised its position in shares of Aetna by 0.8% in the third quarter. Simmons Bank now owns 1,920 shares of the company’s stock valued at $221,000 after buying an additional 15 shares during the period. Finally, DAVENPORT & Co LLC raised its position in shares of Aetna by 0.3% in the second quarter. DAVENPORT & Co LLC now owns 5,761 shares of the company’s stock valued at $704,000 after buying an additional 18 shares during the period. 90.76% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Aetna Inc. (NYSE:AET) traded up 0.90% during trading on Friday, hitting $130.50. 426,621 shares of the company’s stock were exchanged. The stock has a market cap of $45.79 billion, a P/E ratio of 18.82 and a beta of 0.54. The firm has a 50-day moving average price of $114.49 and a 200-day moving average price of $116.30. Aetna Inc. has a one year low of $92.42 and a one year high of $131.08.

Aetna (NYSE:AET) last issued its quarterly earnings data on Thursday, October 27th. The company reported $2.07 EPS for the quarter, topping analysts’ consensus estimates of $2.02 by $0.05. Aetna had a net margin of 3.91% and a return on equity of 16.25%. The business earned $15.78 billion during the quarter, compared to analysts’ expectations of $15.71 billion. During the same period last year, the company posted $1.90 EPS. The business’s revenue was up 5.5% on a year-over-year basis. Equities research analysts expect that Aetna Inc. will post $8.02 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 28th. Shareholders of record on Thursday, October 13th were paid a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, October 11th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.77%. Aetna’s payout ratio is currently 14.49%.

Several research firms have issued reports on AET. Zacks Investment Research upgraded shares of Aetna from a “sell” rating to a “hold” rating in a research report on Tuesday. FBR & Co restated a “hold” rating on shares of Aetna in a research report on Wednesday, August 17th. Credit Suisse Group AG restated a “hold” rating and set a $120.00 price target on shares of Aetna in a research report on Wednesday, August 17th. Jefferies Group restated a “hold” rating on shares of Aetna in a research report on Tuesday, August 23rd. Finally, Sanford C. Bernstein lowered shares of Aetna from an “outperform” rating to a “market perform” rating and set a $132.00 price target for the company. in a research report on Monday, November 14th. Seven analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $132.14.

In related news, Director Jeffrey E. Garten sold 7,100 shares of Aetna stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total transaction of $827,221.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.90% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).

Related posts

Leave a Comment